Evidence map›Paper›PMID 33649539›Full record

ArticleEuropean journal of human genetics : EJHG2021

Lung expression of genes putatively involved in SARS-CoV-2 infection is modulated in cis by germline variants.

Chiara E Cotroneo, Nunzia Mangano, Tommaso A Dragani, Francesca Colombo

Open access · bronzeAbstract read
In one paragraph

Article in European journal of human genetics : EJHG, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Article
  3. Frontiers in immunology · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Serum microRNAs targetingMolecular therapy. Nucleic acids · 2022
    Article
  11. Review
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Chiara E CotroneoDepartment of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Nunzia ManganoDepartment of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Tommaso A DraganiDepartment of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. tommaso.dragani@istitutotumori.mi.it.ORCID http://orcid.org/0000-0001-5915-4598
Francesca ColomboInstitute of Biomedical Technologies, National Research Council (ITB-CNR), Segrate, MI, Italy.
Fondazione IRCCS Istituto Nazionale dei Tumori · ITNational Academies of Sciences, Engineering, and Medicine · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Germline variants in genes involved in SARS-CoV-2 cell entry and in host innate immune responses to viruses may influence the susceptibility to infection. This study used whole-genome analyses of lung tissue to identify polymorphisms acting as expression quantitative trait loci (eQTLs) for 60 genes of relevance to SARS-CoV-2 infection susceptibility. The expression of genes with confirmed or possible roles in viral entry-replication and in host antiviral responses was studied in the non-diseased lung tissue of 408 lung adenocarcinoma patients. No gene was differently expressed by sex, but APOBEC3H levels were higher and PARP12 levels lower in older individuals. A total of 125 cis-eQTLs (false discovery rate < 0.05) was found to modulate mRNA expression of 15 genes (ABO, ANPEP, AP2A2, APOBEC3D, APOBEC3G, BSG, CLEC4G, DDX58, DPP4, FURIN, FYCO1, RAB14, SERINC3, TRIM5, ZCRB1). eQTLs regulating ABO and FYCO1 were found in COVID-19 susceptibility loci. No trans-eQTLs were identified. Genetic control of the expression of these 15 genes, which encode putative virus receptors, proteins required for vesicle trafficking, enzymes that interfere with viral replication, and other restriction factors, may underlie interindividual differences in risk or severity of infection with SARS-CoV-2 or other viruses.

Indexed as

Genetic Predisposition to DiseaseABO Blood-Group SystemCOVID-19GalactosyltransferasesGene Expression RegulationHumansImmunity, InnateLungMicrotubule-Associated ProteinsPolymorphism, GeneticQuantitative Trait LociReceptors, VirusSARS-CoV-2ABO Blood-Group SystemABO protein, humanFYCO1 protein, humanGalactosyltransferasesMicrotubule-Associated ProteinsReceptors, Virus

Identifiers

PMID33649539
PMCPMC7917374
OpenAlexW3134164822

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.